Log in to your Inderes Free account to see all free content on this page.
Create account

Acarix

0.29 SEK

-1.19 %

Less than 1K followers

ACARIX

First North Stockholm

Medical Equipment & Services

Health Care

-1.19 %
+2.48 %
+12.43 %
+8.02 %
+1.94 %
+30.11 %
-41.05 %
-72.65 %
-96.08 %

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.

Read more
Market cap
359.14M SEK
Turnover
88.19K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
14.5.
2026

Interim report Q1'26

17.6.
2026

General meeting '26

13.8.
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Forum discussions
On my journey in search of a new Revenio, in a country where vague Finland-Swedish was spoken and which was ruled by Carl XVI Gustaf, I came across a company called Acarix. And I’m not comparing this to be a new Revenio. For the diagnosis of coronary artery disease, a common basic...
9/8/2021, 5:11 AM
by Fisu
9
Expected SEK 79 million share issue now underway: https://acarix.com/wp-content/uploads/2021/11/acarixpralmeria-prospekteng.pdf
12/6/2021, 12:06 AM
by Pohjolan Eka
3
Tärkeimmät talousuutiset | Kauppalehti – 27 Jun 19 Acarix CADScor®System included in NICE guidelines (UK) Tärkeimmät ajankohtaiset talousuutiset, pörssikurssit ja kattavat sijoittajapalvelut löydät Kauppalehdestä. Here’s a slightly older bulletin. An interesting product, which has...
9/8/2021, 7:32 AM
by PP2020
3
Interesting that the analyst firm is also an advisor.. Are they also an investor?
9/8/2021, 5:33 AM
by Yoda
3
Redeye’s website does have a Disclosures section for the company in question, which states whether Redeye owns the company. In this case, it does not. redeye.se Acarix Disclosures - Redeye Discover the latest equity research on Acarix.
9/8/2021, 2:45 PM
by Llopardi
2
PubMed Economic Analysis of the CADScor System for Ruling Out Coronary Artery... The CADScor System is a potentially cost-saving test for the diagnosis of CAD. When initiated before the use of non-invasive cardiac imaging tests such as computed tomography coronary angiography, the...
9/8/2021, 5:40 AM
by PP2020
2
News from America has arrived; I don’t know how to post it here. Thanks in advance
10/27/2021, 11:02 AM
by Hollitupa
1
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.